Literature DB >> 1155716

Methionine-induced hepatic coma in dogs.

G E Merino, T Jetzer, W M Doizaki, J S Najarian.   

Abstract

Oral methionine is noncomatogenic in normal dogs, but it is consistently comatogenic in dogs with portacaval shunts in the presence of elevated ammonia levels. Such action appears to be enhanced by the ammonia itself, since relatively small doses of oral methionine can induce coma when baseline levels of ammonia are above 1,000 mug/100 ml; much higher doses are nesessary for near normal ammonemia. The methionine-induced coma closely reproduces the clinical and electroencephalographic picture of coma in other canine models. Oral methionine does not significantly increase the ammonia levels, but its action is probably mediated by the release of methanethiol (and other less active compounds) from the bowel. Methanethiol levels tend to increase in proportion to the amount of methionine administered, and its comatogenic action may be amplified, up to one hundredfold, by high ammonia levels. Methanethiol levels in comatose patients and the concept of the synergistic effect with ammonia may lead to a clearer understanding of certain enterogenous and dietetic forms of hepatic encephalopathy in cirrhotic patients. The lowering of ammonia levels by hemodialysis or methanethiol levels by activated charcoal hemoperfusion, as attempts to reverse such forms of coma, warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155716     DOI: 10.1016/0002-9610(75)90454-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Methionine transamination--metabolic function and subcellular compartmentation.

Authors:  P W Scislowski; K Pickard
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

2.  Effects of intraduodenal feeding of a branched-chain amino acid-rich solution on ammonia-induced encephalopathy in liver-injured rats.

Authors:  S Hayashi; A Watanabe; T Shiota; T Obata; N Takei; T Sakata; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1982-12

3.  Impaired metabolism of methionine in severe liver diseases. I. Clinical and pathophysiological significance of elevated serum methionine levels.

Authors:  T Higashi
Journal:  Gastroenterol Jpn       Date:  1982-04

4.  Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.

Authors:  T Higashi
Journal:  Gastroenterol Jpn       Date:  1982-04

5.  Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy.

Authors:  C J McClain; L Zieve; W M Doizaki; S Gilberstadt; G R Onstad
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

Review 6.  Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.

Authors:  Min Seob Kwak; Jae Myung Cha; Jin Young Yoon; Jung Won Jeon; Hyun Phil Shin; Hye Jung Chang; Hyung Kyung Kim; Kwang Ro Joo; Joung Il Lee
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.